Benzodiazepines in the treatment of epilepsy. A review.
D000328:Adult; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D002707:Chlordiazepoxide / Q000009:adverse effects / Q000627:therapeutic use*; D003975:Diazepam / Q000009:adverse effects / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004461:Eclampsia / Q000188:drug therapy; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000209:etiology; D004832:Epilepsy, Absence; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D007223:Infant; D008027:Light / Q000009:adverse effects; D009207:Myoclonus / Q000188:drug therapy; D009567:Nitrazepam / Q000009:adverse effects / Q000627:therapeutic use*; D010076:Oxazepam / Q000009:adverse effects / Q000627:therapeutic use*; D010433:Pentylenetetrazole; D011247:Pregnancy; D012640:Seizures / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy
D000927:Anticonvulsants; D010076:Oxazepam; D002707:Chlordiazepoxide; D009567:Nitrazepam; D003975:Diazepam; D010433:Pentylenetetrazole